SUMMARY Formalin infiltration of the ductus arteriosus was performed in 13 neonates with pulmonary atresia (three with ventricular septal defect, two with tricuspid atresia, and eight with intact ventricular septum, one of whom had Ebstein's anomaly) in an attempt to maintain duct patency. Nine patients had an additional retrograde pulmonary valvotomy and one a Blalock-Taussig shunt. The mean preoperative systemic Po2 was 31 mmHg and rose significantly to 46 mmHg after operation. However, the Po2 rose in only two of four patients who had formalin infiltration alone. There were five early deaths and three had clinical evidence of duct closure. Four patients needed further surgery (systemicpulmonary artery shunt) within eight days. Seven of eight surviving patients were shown to have a closed duct at repeat cardiac catheterisation (two to 13 months after operation). The eighth died before restudy. There were four late deaths, one following late reoperation and the other three within five months of early reoperation.
In some congenital cardiac conditions pulmonary blood flow is dependent, either largely or exclusively, on patency of the ductus arteriosus. When this structure constricts, in the neonatal period, progressive hypoxaemia and acidaemia result. The introduction of prostaglandin infusion to maintain patency of the ductus arteriosus in the short term has facilitated management, but palliative surgery is still required to establish adequate pulmonary blood flow on a more permanent basis. This may involve either a pulmonary valvotomy and/or a systemic to pulmonary shunt. Rudolph et al. 1 described, in 1975, a technique of infiltrating the ductus arteriosus with formalin in an attempt to maintain its long-term patency. Four cases were described with good short-term results. Between 1977 and October 1979 formalin infiltration of the ductus arteriosus was performed in 13 neonates at The Hospital for Sick Children, Great Ormond Street. This communication reports our experience with the technique.
Received for publication 27 November 1980 Subjects and methods Ductus infiltration was undertaken as part of the surgical management of 13 patients with ductdependent congenital heart disease. There were eight cases of pulmonary atresia with intact ventricular septum, one of whom had Ebstein's malformation of the tricuspid valve, three cases of pulmonary atresia with ventricular septal defect, and two cases of pulmonary atresia with tricuspid atresia.
The technique followed for formalin infiltration was as described by Rudolph et al.1 Ten per cent formaldehyde solution coloured with methylene blue was injected beneath the adventitia of the ductus arteriosus, an attempt being made to infiltrate the whole circumference. The spread of the blue dye was a good indicator of the extent of the infiltration.
The records of the 13 patients were reviewed retrospectively. Details of diagnosis and the surgical procedures associated with the duct infiltration were noted. Pre-and postoperative arterial Po2 were recorded and, if prostaglandin infusion was used perioperatively, its influence on the arterial P02 noted. In order to assess the longterm patency of the ductus arteriosus, survival after duct infiltration, clinical evidence of duct patency, postoperative cardiac catheterisation data, the need for further surgery, and necropsy findings were reviewed.
A paired sample t test was employed to test the significance of changes in arterial Po2 resulting from surgery and prostaglandin infusion.
Results
The diagnosis, age at initial surgery, and type of initial surgery of the 13 patients are shown in the Table. ary valvotomy was carried out in nine patients and a left modified Blalock-Taussig shunt with a 4 mm Gortex conduit in one patient.2 Fig. 1 shows the systemic arterial Po0 levels at presentation, after prostaglandin treatment, and after operation (prostaglandin treatment having been withdrawn). The mean systemic arterial Po2 at presentation was 31 mmHg (standard error of mean 2 6) and after surgery 46 mmHg (SEM 3-4).
The improvement in systemic arterial Po0 on prostaglandin treatment was significant (p <0001) and this improvement was maintained when prostaglandin was stopped after operation (p < 0.01).
In the four patients who underwent duct infiltration as the sole procedure (cases 1, 2, 3, and 4), however, the systemic arterial Po2 improved in two, remained unchanged in one, and fell in one case. Cardiac catheterisation and angiocardiography were performed in seven of the eight patients who survived early operation, between two and 13 months (median eight months) after duct infiltration. One patient (case 4) died at home before repeat catheterisation could be arranged. In no case was the ductus arteriosus found to be patent. Four patients had undergone early reoperation (a systemic to pulmonary shunt) before restudy.
Late reoperation Three patients (cases 5, 7, and 8) required a second operation for increasing cyanosis between eight and 10 months after the initial duct infiltration. This followed restudy which had shown closure of the ductus arteriosus. Case 7 underwent a right Blalock-Taussig shunt and cases 5 and 8 had a patch enlargement of the right ventricular outflow tract. Case 5 died in the early postoperative period.
Late death
There were four late deaths. One patient (case 5) died after late reoperation and the ductus arteriosus was closed at necropsy. The other three patients (cases 4, 11, and 13) died after discharge from hospital, at two, three, and five months after early reoperation (systemic to pulmonary shunt). In all three a closed ductus arteriosus was found at necropsy.
The outcome of the 13 patients who underwent duct infiltration is summarised in Fig. 2 
Discussion
Formalin infiltration of the ductus arteriosus was introduced as a contribution to the management of infants with duct-dependent congenital heart disease in whom the standard procedures of pulmonary valvotomy and/or systemic to pulmonary shunt were not feasible or were inadequate.' Good results have been reported when the technique was used as an adjunct to valvotomy and infundibuloplasty,3 but others have found it to be less successful when used alone. 4 We have used the technique alone or in combination with pulmonary valvotomy in 13 patients. The aim of the procedure, however employed, has been to maintain duct patency and thus ensure adequate pulmonary blood flow in the medium term.
In our experience, formalin infiltration did not ensure duct patency even in the very short term.
The majority of patients were weaned successfully from prostaglandin infusion without a significant fall in the systemic arterial P02. However, in four cases the systemic arterial Po2 fell when prostaglandins were discontinued, and three of the patients who died early had lost the continuous murmur, suggesting duct closure. Four patients required urgent shunt procedures for increasing cyanosis within eight days of duct infiltration, and all surviving patients had occluded ducts at recatheterisation, between two and 13 months after operation. In only two patients, both dying at two and eight days after operation from non-cardiac complications of operation, was the duct found to be patent at necropsy.
All our patients had pulmonary atresia: with either an intact ventricular septum, a ventricular septal defect, or tricuspid atresia. They constitute a group of neonates in whom the overall mortality is very high and for whom the best approach to management remains controversial. When feasible, a good pulmonary valvotomy offers, in theory, the best palliation, establishing forward flow through a usually hypoplastic right ventricle, and improving pulmonary blood flow. The only child in the series surviving without reoperation (case 9) had a retrograde pulmonary valvotomy performed at the initial operation and was shown to have excellent right ventricular growth at follow-up. Pulmonary valvotomy is generally performed through a left thoracotomy which, in the presence of a left aortic arch, makes the creation of a Blalock-Taussig shunt or an aortopulmonary (Waterston) anastomosis difficult. Duct infiltration thus seemed an attractive alternative to contralateral thoracotomy for a shunt procedure, when pulmonary valvotomy alone was considered inadequate, on the operating table. Over the past four years in this unit, the use of a Gortex prosthesis as a subclavian to pulmonary artery conduit has largely overcome this particular problem.2 Nevertheless, even this alternative may fail for technical reasons, with the diminutive pulmonary and subclavian arteries of the neonate. Duct infiltration was, therefore, employed as a "holding manoeuvre" in the sick infant unfit for bilateral thoracotomy. Our experience with formalin infiltration, however, even in the short term, suggests that its efficacy is unpredictable-four patients required urgent intervention for deterioration with a clinically closing ductus while still in hospital. Long-term administration of prostaglandin orally may provide more predictable duct patency in the difficult situation of the sick neonate with an inadequate pulmonary valvotomy and a failed shunt on one side, if it is felt that further growth ofthe patient would increase the chance of a successful shunt on the other side.5 There is little experience with this form of treatment and the incidence of side effects from long-term prostaglandin treatment is unknown.
Thus, in our experience, formalin infiltration of the ductus arteriosus is no substitute for a shunt operation. Since the short-term effects of duct infiltration can be more reliably achieved by prostaglandin infusion, we have abandoned the procedure and would not recommend its use.
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